Using Anti-Müllerian Hormone and Serum Estradiol to Predict Ovarian Hyperstimulation Syndrome in Patients Using Antagonist Protocol During IVF/ICSI Cycles

Serum Anti-Mullerian Hormone, Follicle Stimulating Hormone and Antral Follicle Count Measurement as a Prediction for Pregnancy Rates in IVF/ICSI cycle

Comparative Study of Anti-Mullerian Hormone, inhibin-B, and Three-Dimensional Ultrasound Determinants of Ovarian Reserve in Patients Undergoing ICSI

Soft versus Conventional Protocol in Ovarian Stimulation in Intracytoplasmic Sperm Injection Cycles for Poor Responders: A randomized clinical trial

LOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS

Dual triggering for final oocyte maturation compared to single triggering in GnRH antagonist (IVF-ICSI) protocols (Randomized Controlled Trial)

Antagonist/letrozole protocol versus microdose flare-up protocol in poor responders: a randomized study

Intracytoplasmic Sperm Injection Outcome in Patient at Risk of Poor Responder Using Mild Ovarian Stimulation Protocol versus Short Gonadotropin Releasing Hormone Agonist Protocol

Anti-Mullerian Hormone Serum Concentrationsin Women with Polycystic Ovaries and Normoovulatory Women of Reproductive Age

PROGESTIN-PRIMED OVARIAN STIMULATION VERSUS GNRH ANTAGONIST IN LOW OVARIAN RESERVE PATIENTS UNDERGOING ICSI CYCLES